Table:
begin	end	state
1	35	cytoplasmic
36	53	transmembrane
54	61	non-cytoplasmic
62	83	transmembrane
84	94	cytoplasmic
95	115	transmembrane
116	120	non-cytoplasmic
121	146	transmembrane
147	159	cytoplasmic
160	184	transmembrane
185	195	non-cytoplasmic
196	216	transmembrane
217	244	cytoplasmic
245	265	transmembrane
266	284	non-cytoplasmic
285	305	transmembrane
306	314	cytoplasmic
315	334	transmembrane
335	339	non-cytoplasmic
340	364	transmembrane
365	375	cytoplasmic
376	396	transmembrane
397	406	non-cytoplasmic
407	426	transmembrane
427	438	cytoplasmic

Input:
>AO353_04405
MTTSTTYSDAVPAQPTNSTTRVATASFIGTAIEFYDFYVYATAAALVIGPVFFPQTSGTA
QMLSAFLTFGIAFLARPLGSALFGHFGDRIGRKSTLVASLLLMGVCTTLIGVLPGYESIG
AWAPILLCVLRFGQGLGLGGEWGGAALLATENAPKGKRAWFGMFPQLGPSIGFLAANGLF
LTLAMTLNDEQFRSWGWRIPFLLSAVLVMVGLYVRLKLHETPVFANAMARQERVKIPLVE
LFSQYWAPMLLGAAAMVVCYALFYISTVFSLSYGVSTLGYSRETFLGLLCFAVLFMAAAT
PLSAWASDRFGRKPVLIIGGVLAILSGFTMEPLLTHGTTWGVALFLCIELFLMGVTFAPM
GALLPELFPTRVRYTGASAAYNLGGIVGASAAPFFAQKLVAMGGLSWVGGYVSAAAVISL
IAVLCLKETRHNDLNQVA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server